FDA authorizes Novavax's updated Covid vaccine targeting JN.1 strain
The Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax’s Covid shot.
The Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax’s Covid shot.
The updated vaccine is authorized for use in individuals 12 years of age and older and will target the JN.1 strain of the virus.
Shares of the company were up 9% in late afternoon trading.
A healthcare worker prepares a dose of the Novavax vaccine at a pharmacy in Schwenksville, Penn., in 2022.Hannah Beier / Bloomberg via Getty Images file“Today’s authorization provides an additional Covid-19 vaccine option,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.
Doses are on track to be available as early as the end of next week, the company said in an emailed response.
Rating: 5